Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device
Launched by MINISTRY OF HEALTH, ZAMBIA · Apr 24, 2017
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
To assess the safety and acceptability of the non-surgical PrePex device among healthy adult male participants scheduled for voluntary medical male circumcision when removing the foreskin shortly after device placement.
Five hundred (500) males scheduled for voluntary circumcision performed by clinicians or nurses using the PrePex.
Theses clinicians and nurses have already been trained in the Prepex procedure and will undergo further training in the modification to the technique. Study duration per participant will be up to 8 weeks and will include three follow up visits and one phone cal...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Ages - 13 to 49 years
- • Uncircumcised
- • Participant wants to be circumcised
- • Participant assent to the procedure
- • Legal guardian consent to the procedure for ages 13-18 years
- • Able to understand the study procedures and requirements
- • Agrees to abstain from sexual intercourse for 8 weeks after circumcision
- • Agrees to abstain from masturbation for at least 2 weeks after Removal
- • Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 7 weeks post removal (8 weeks total)
- • Participant able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
- Exclusion Criteria:
- • Legal guardian withholds consent for ages 13-18 years
- • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the participant from undergoing a circumcision
- • Participant with the following diseases/conditions: phimosis, paraphimosis, adhesions, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
- • Known bleeding / coagulation abnormality, uncontrolled diabetes
- • Participant that to the opinion of the investigator is not a good candidate
- • Diabetes Mellitus
- • HIV Sero-positive
About Ministry Of Health, Zambia
The Ministry of Health, Zambia, is a governmental body dedicated to enhancing public health outcomes and promoting healthcare advancements within the country. As a clinical trial sponsor, the Ministry plays a crucial role in facilitating research initiatives aimed at addressing pressing health challenges faced by the Zambian population. With a commitment to evidence-based practices, the Ministry collaborates with local and international stakeholders to ensure rigorous study design, ethical compliance, and the effective translation of research findings into health policy and practice. Through its sponsorship of clinical trials, the Ministry of Health aims to foster innovation, improve health interventions, and ultimately contribute to the overall well-being of the Zambian people.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lusaka, Lusaka Province, Zambia
Livingstone, , Zambia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials